Chitosan Dermal Substitute and Chitosan Skin Substitute Contribute to Accelerated Full-Thickness Wound Healing in Irradiated Rats

Figure 7

HLA (green fluorescence) was incorporated into wounds on days 7 ((a), (d)), 14 ((b), (e)), and 21 ((c), (f)). The positive control of human skin (g). The negative control of chitosan dermal substitute-treated wounds (h) and duoderm-treated wounds (i). The epidermis and dermis are demarcated via the dash dotted lines. Nuclei stained blue. Scale bar: 20 µm.